Skip to content
Back home
FAIRVASC – building registry interoperability to inform clinical care
  • HOME
    • HOME_1.0
  • THE PROJECT
  • Interviews
  • ABOUT THE DISEASE (AAV)
  • FAIRVASC consortium
  • REGISTRIES
    • FAIRVASC Onboarding Handbook
  • PATIENT ADVOCACY ORGANISATIONS
    • Your FAIRVASC questions answered!
  • NEWS
  • MEDIA
  • RELATED PROJECTS
  • CONTACT US
  • Search
Back home
  • Search
  • HOME
    • HOME_1.0
  • THE PROJECT
  • Interviews
  • ABOUT THE DISEASE (AAV)
  • FAIRVASC consortium
  • REGISTRIES
    • FAIRVASC Onboarding Handbook
  • PATIENT ADVOCACY ORGANISATIONS
    • Your FAIRVASC questions answered!
  • NEWS
  • MEDIA
  • RELATED PROJECTS
  • CONTACT US
Home » News » Interview with Kris McGlinn
News

Interview with Kris McGlinn

by nowak|Published 22 March 2022

Interview with Kris McGLinn about the role and tasks of QIT in FAIRVASC project has been published

You may also like

FAIRVASC project presented at the EUVAS and UKVAS meetings
Published 21 January 2021

FAIRVASC project presented at the EUVAS and UKVAS meetings

FAIRVASC Technical Coordinator Professor Mark Little recently presented the FAIRVASC project at the EUVAS and UKVAS meetings on 02 and 12 Nov […]

Published 9 July 2024

The EULAR grant for FIARVASC

Application for a clinical RMD research methodology was approved by the EULAR research Committee on the 12th of MARCH 2024, for a total […]

FAIRVASC presented in Dutch patient organization magazine
Published 21 January 2021

FAIRVASC presented in Dutch patient organization magazine

Peter Verhoeven (chairman Vasculitis NL) writes about FAIRVASC in the magazine (Vascuzine) of their Dutch patient organization. Please find both the Dutch […]

Published 6 May 2022

FAIRVASC actively participates in the 20th International Vasculitis and ANCA Workshop 03-06 April 2022 and Patient Event

The FAIRVASC consortium had a very active involvement at the 20th International Vasculitis and ANCA Workshop 03-06 April 2022, held in Dublin, […]

Project Start date: 01 June 2020 Project Duration: 36 months Project Budget: €2,299,091 No of partners: 10 No of Patient Advocacy Organisations: 3
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the EJP RD COFUND-EJP N° 825575

© 2026  – All rights reserved

Powered by  – Designed with the Customizr Theme